, Latest global cancer data, 2018.

, Institut National du Cancer, 2019.

R. Siegel, J. Ma, Z. Zou, and A. Jemal, Cancer statistics, CA Cancer J Clin, 2014.

, CA Cancer J Clin, vol.64, issue.1, pp.9-29, 2014.

R. A. Weinberg, The biology of cancer, Garland Science, 2014.

E. D. Hay, An overview of epithelio-mesenchymal transformation, Acta Anat (Basel), vol.154, issue.1, pp.8-20, 1995.

M. A. Nieto, The ins and outs of the epithelial to mesenchymal transition in health and disease, Annu Rev Cell Dev Biol, vol.27, pp.347-76, 2011.

P. Savagner, Epithelial-mesenchymal transitions: from cell plasticity to concept elasticity, Curr Top Dev Biol, vol.112, pp.273-300, 2015.

C. E. Weber, N. Y. Li, P. Y. Wai, and P. C. Kuo, Epithelial-mesenchymal transition, TGF-?, and osteopontin in wound healing and tissue remodeling after injury, J Burn Care Res, vol.33, issue.3, pp.311-319, 2012.

S. Gurzu, S. Turdean, A. Kovecsi, A. O. Contac, and I. Jung, Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update, World J Clin Cases, vol.3, issue.5, pp.393-404, 2015.

M. W. Klymkowsky and P. Savagner, Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe, Am J Pathol, vol.174, issue.5, pp.1588-93, 2009.

R. C. Stone, I. Pastar, N. Ojeh, V. Chen, S. Liu et al., Tomic-Canic M. Epithelial-mesenchymal transition in tissue repair and fibrosis, Cell Tissue Res, vol.365, issue.3, pp.495-506, 2016.

B. Byer and J. P. Thiery, Epithelium-mesenchyme interconversion as example of epithelial plasticity, APMIS, vol.101, issue.4, pp.257-68, 1993.

J. A. Davies, Mesenchyme to epithelium transition during development of the mammalian kidney tubule, Acta Anat (Basel), vol.156, issue.3, pp.187-201, 1996.

M. A. Nieto, Epithelial plasticity: a common theme in embryonic and cancer cells, Science, vol.342, issue.6159, p.1234850, 2013.

J. P. Thiery and J. P. Sleeman, Complex networks orchestrate epithelial-mesenchymal transitions, Nat Rev Mol Cell Biol, vol.7, issue.2, pp.131-173, 2006.

S. Lamouille, J. Xu, and R. Derynck, Molecular mechanisms of epithelial-mesenchymal transition, Nat Rev Mol Cell Biol, vol.15, issue.3, pp.178-96, 2014.

H. Acloque, M. S. Adams, K. Fishwick, M. Bronner-fraser, and M. A. Nieto, Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease, J Clin Invest, vol.119, issue.6, pp.1438-1487, 2009.
URL : https://hal.archives-ouvertes.fr/hal-02912722

M. Zeisberg and E. G. Neilson, Biomarkers for epithelial-mesenchymal transitions, J Clin Invest, vol.119, issue.6, pp.1429-1466, 2009.

A. N. Kothari, Z. Mi, M. Zapf, and P. C. Kuo, Novel clinical therapeutics targeting the epithelial to mesenchymal transition, Clin Transl Med, vol.3, p.35, 2014.

B. De-craene, F. Van-roy, and G. Berx, Unraveling signalling cascades for the Snail family of transcription factors, Cell Signal, vol.17, issue.5, pp.535-582, 2005.

V. Comaills, L. Kabeche, R. Morris, R. Buisson, M. Yu et al., Genomic Instability Is Induced by Persistent Proliferation of Cells Undergoing Epithelial-to-Mesenchymal Transition, Cell Rep, vol.17, issue.10, pp.2632-2647, 2016.

I. J. Fidler and G. Poste, The "seed and soil" hypothesis revisited, Lancet Oncol, vol.9, issue.8, p.808, 2008.

T. Brabletz, A. Jung, S. Reu, M. Porzner, F. Hlubek et al., Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment, Proc Natl Acad Sci U S A, vol.98, issue.18, pp.10356-61, 2001.

M. Zeisberg, A. A. Shah, and R. Kalluri, Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney, J Biol Chem, vol.280, issue.9, pp.8094-100, 2004.

N. P. Gunasinghe, A. Wells, E. W. Thompson, and H. J. Hugo, Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer, Cancer Metastasis Rev, vol.31, issue.3-4, pp.469-78, 2012.

E. D. Williams, D. Gao, A. Redfern, and E. W. Thompson, Controversies around epithelial-mesenchymal plasticity in cancer metastasis, Nat Rev Cancer, vol.19, issue.12, pp.716-732, 2019.

T. Brabletz, R. Kalluri, M. A. Nieto, and R. A. Weinberg, EMT in cancer, Nat Rev Cancer, vol.18, issue.2, pp.128-134, 2018.

X. Ye and R. A. Weinberg, Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression, Trends Cell Biol, vol.25, issue.11, pp.675-686, 2015.

M. Yu, A. Bardia, B. S. Wittner, S. L. Stott, M. E. Smas et al., Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition, Science, vol.339, issue.6119, pp.580-584, 2013.

M. K. Jolly, M. Boareto, B. Huang, D. Jia, M. Lu et al., Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis. Front Oncol, vol.5, p.155, 2015.

X. Liu, J. Li, B. L. Cadilha, A. Markota, C. Voigt et al., Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis. Sci Adv, vol.5, p.4275, 2019.

V. L. Payen, P. E. Porporato, B. Baselet, and P. Sonveaux, Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway, Cell Mol Life Sci, vol.73, issue.7, pp.1333-1381, 2016.

W. Hua, P. Ten-dijke, S. Kostidis, M. Giera, and M. Hornsveld, TGF?-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer, Cell Mol Life Sci, 2019.

A. Morandi, M. L. Taddei, P. Chiarugi, and E. Giannoni, Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors. Front Oncol, vol.7, p.40, 2017.

S. Y. Lee, H. M. Jeon, M. K. Ju, E. K. Jeong, C. H. Kim et al., Dlx-2 is implicated in TGF-?-and Wnt-induced epithelial-mesenchymal, glycolytic switch, and mitochondrial repression by Snail activation, Int J Oncol, vol.46, issue.4, pp.1768-80, 2015.

L. Yang, Y. Hou, J. Yuan, S. Tang, H. Zhang et al., Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways, Oncotarget, vol.6, issue.28, pp.25755-69, 2015.

U. Kern, V. Wischnewski, M. L. Biniossek, O. Schilling, and T. Reinheckel, Lysosomal protein turnover contributes to the acquisition of TGF?-1 induced invasive properties of mammary cancer cells, Mol Cancer, vol.14, p.39, 2015.

J. Li, L. Dong, D. Wei, X. Wang, S. Zhang et al., Fatty acid synthase mediates the epithelial-mesenchymal transition of breast cancer cells, Int J Biol Sci, vol.10, issue.2, pp.171-80, 2014.

L. Jiang, L. Xiao, H. Sugiura, X. Huang, A. Ali et al., Metabolic reprogramming during TGF?1-induced epithelial-to-mesenchymal transition, Oncogene, vol.34, issue.30, pp.3908-3924, 2015.

D. Kong, A. Ahmad, B. Bao, Y. Li, S. Banerjee et al., Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells, PLoS One, vol.7, issue.9, 2012.

C. Scheel, E. N. Eaton, S. H. Li, C. L. Chaffer, F. Reinhardt et al., Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast, Cell, vol.145, issue.6, pp.926-966, 2011.

J. Guinney, R. Dienstmann, X. Wang, A. De-reyniès, A. Schlicker et al., The consensus molecular subtypes of colorectal cancer, Nat Med, vol.21, issue.11, pp.1350-1356, 2015.

A. Sadanandam, C. A. Lyssiotis, and K. Homicsko, A colorectal cancer classification system that associates cellular phenotype and responses to therapy, Nat Med, vol.19, p.619, 2013.

D. Sousa, E. Melo, F. Wang, X. Jansen, and M. , Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions, Nat Med, vol.19, p.614, 2013.

L. Marisa, A. De-reyniès, and A. Duval, Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value, PLoS Med, vol.10, p.1001453, 2013.

M. Cheng, FLNA promotes chemoresistance of colorectal cancer through inducing epithelial-mesenchymal transition and smad2 signaling pathway, Am J Cancer Res, vol.10, issue.2, pp.403-423, 2020.

Y. Takahashi, G. Sawada, J. Kurashige, T. Matsumura, R. Uchi et al., Tumor-derived tenascin-C promotes the epithelialmesenchymal transition in colorectal cancer cells, Anticancer Res, vol.33, issue.5, pp.1927-1961, 2013.

J. Li, B. Li, C. Ren, Y. Chen, X. Guo et al., The clinical significance of circulating GPC1 positive exosomes and its regulative miRNAs in colon cancer patients, Oncotarget, vol.8, issue.60, pp.101189-101202, 2017.

X. Huang, L. Xiang, Y. Li, Y. Zhao, H. Zhu et al.,

, Signaling Axis Regulates the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer, Cell Physiol Biochem, vol.47, issue.2, pp.590-603, 2018.

D. Jeong, S. Heo, S. Ahn, T. Lee, S. Park et al., Jun Baek M. Cyr61 expression is associated with prognosis in patients with colorectal cancer, BMC Cancer, vol.14, p.164, 2014.

Y. Bie, W. Ge, Z. Yang, X. Cheng, Z. Zhao et al., The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis. Dis Markers, p.8023460, 2019.

, IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review), Int J Oncol, vol.48, issue.1, pp.5-12, 2016.

J. D. Yang, L. Ma, and Z. Zhu, SERPINE1 as a cancer-promoting gene in gastric adenocarcinoma: facilitates tumour cell proliferation, migration, and invasion by regulating, EMT. J Chemother, issue.7-8, pp.408-418, 2019.

M. Foroutan, J. Cursons, S. Hediyeh-zadeh, E. W. Thompson, and M. J. Davis, A Transcriptional Program for Detecting TGF?-Induced EMT in Cancer, Mol Cancer Res, vol.15, issue.5, pp.619-631, 2017.

X. Liu, D. Xu, Z. Liu, Y. Li, C. Zhang et al., THBS1 facilitates colorectal liver metastasis through enhancing epithelial-mesenchymal transition, Clin Transl Oncol, 2020.

J. Luo, H. Yang, and B. L. Song, Mechanisms and regulation of cholesterol homeostasis, Nat Rev Mol Cell Biol, vol.21, issue.4, pp.225-245, 2019.

M. S. Brown and J. L. Goldstein, The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, Cell, vol.89, pp.331-340, 1997.

J. D. Horton, J. L. Goldstein, and M. S. Brown, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J Clin Invest, vol.109, issue.9, pp.1125-1156, 2002.

. Binlu-huang1, Bao-liang Song 2 and Chenqi Xu Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities, Nat Met, pp.132-141, 2020.

C. Ginestier, F. Monville, J. Wicinski, O. Cabaud, N. Cervera et al., Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target. Stem Cells, vol.30, pp.1327-1364, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01431941

M. G. Waugh, S. Minogue, J. S. Anderson, M. Santos, and J. J. Hsuan, Signalling and non-caveolar rafts, Biochem Soc Trans, vol.29, pp.509-520, 2001.

D. G. Menter, V. P. Ramsauer, S. Harirforoosh, K. Chakraborty, P. Yang et al., Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites, PLoS ONE, 2011.

L. N. Griner, K. L. Mcgraw, J. O. Johnson, A. F. List, and G. W. Reuther, JAK2V617F-mediated signalling is dependent on lipid rafts and statins inhibit JAK2-V617F-dependent cell growth, Br J Haematol, vol.160, pp.177-87, 2013.

J. Frasor, J. M. Danes, B. Komm, K. C. Chang, C. R. Lyttle et al., Profiling of estrogen up-and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype, Endocrinology, vol.144, issue.10, pp.4562-74, 2003.

R. Sirianni, F. Zolea, A. Chimento, C. Ruggiero, L. Cerquetti et al., Targeting estrogen receptor-? reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment, J Clin Endocrinol Metab, vol.97, issue.12, pp.2238-50, 2012.

E. J. Filardo, A role for G-protein coupled estrogen receptor (GPER) in estrogeninduced carcinogenesis: Dysregulated glandular homeostasis, survival andmetastasis, J Steroid Biochem Mol Biol, vol.176, pp.38-48, 2018.

A. Chimento, I. Casaburi, P. Avena, F. Trotta, D. Luca et al., Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment. Front Endocrinol (Lausanne), vol.9, p.807, 2019.

B. Wang, X. Rong, E. Palladino, J. Wang, A. M. Fogelman et al., Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis, Cell Stem Cell, vol.22, issue.2, pp.206-220, 2018.

J. H. Kim, C. N. Kim, and D. W. Kang, Squalene Epoxidase Correlates E-Cadherin Expression and Overall Survival in Colorectal Cancer Patients: The Impact on Prognosis and Correlation to Clinicopathologic Features, J Clin Med, vol.8, issue.5, 2019.

W. Hua, P. Ten-dijke, S. Kostidis, M. Giera, and M. Hornsveld, TGF?-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer, Cell Mol Life Sci, 2019.

L. Yang, F. Zhang, X. Wang, Y. Tsai, K. H. Chuang et al., A FASN-TGF-?1-FASN regulatory loop contributes to high EMT/metastatic potential of cisplatin-resistant non-small cell lung cancer, Oncotarget, vol.7, issue.34, pp.55543-55554, 2016.

C. M. Hung, D. H. Kuo, C. H. Chou, Y. C. Su, C. T. Ho et al., Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells, J Agric Food Chem, vol.59, issue.17, pp.9683-90, 2011.

A. Morandi, M. L. Taddei, P. Chiarugi, and E. Giannoni, Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors. Front Oncol, vol.7, p.40, 2017.

L. Jiang, L. Xiao, H. Sugiura, X. Huang, A. Ali et al., Metabolic reprogramming during TGF?1-induced epithelial-to-mesenchymal transition, Oncogene, vol.34, issue.30, pp.3908-3924, 2015.

V. S. Lebleu, J. T. O'connell, G. Herrera, K. N. Wikman, H. Pantel et al., PGC-1? mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis, Nat Cell Biol, vol.16, issue.10, pp.1-15, 2014.

G. Linara, Cholesterol deprivation induces TGF? signaling to promote basal differentiation in pancreatic cancer, BioRxiv, 2019.

B. Sharma, V. Gupta, D. Dahiya, H. Kumar, K. Vaiphei et al., Clinical relevance of cholesterol homeostasis genes in colorectal cancer, Biochim Biophys Acta Mol Cell Biol Lipids, issue.10, pp.1314-1327, 1864.

M. Dobrzycka, P. Spychalski, A. J. ?achi?ski, P. Kobiela, P. J?drusik et al., Statins and Colorectal Cancer -A Systematic Review, Exp Clin Endocrinol Diabetes, vol.128, issue.4, pp.255-262, 2020.

U. Ravnskov, K. S. Mccully, and P. J. Rosch, The statin-low cholesterol-cancer conundrum, QJM, vol.105, issue.4, pp.383-391, 2012.

X. Ding, W. Zhang, S. Li, and H. Yang, The role of cholesterol metabolism in cancer, Am J Cancer Res, vol.9, issue.2, pp.219-227, 2019.

U. Ravnskov, Statins do not protect against cancer: quite the opposite, J Clin Oncol, 2015.

S. F. Nielsen, B. G. Nordestgaard, and S. E. Bojesen, Statin use and reduced cancerrelated mortality, N Engl J Med, vol.368, issue.6, pp.576-583, 2013.

V. Comailss, 21) comme conséquence de l'induction de la transition épithéliale-mésenchymateuse : l'apparition d'erreurs de cytokinèse avec formation conséquente de cellules bi/polynucléées, 2016.

A. , ligne du haut) Apparition d'un grand nombre de cellules bi/polynucléées dans les cellules traitées (à droite) par rapport au cellules non traitée

B. , ligne du bas) Le pourcentage de cellules bi/polynucléées, après comptage sur 500 cellules non traitée (à gauche) et 500 cellules traitées (à droite)